Comorbidities and causes of death in the management of localized T1a kidney cancer.

Author: AllafMohamad Ezzeddine, BallMark W, GorinMichael A, HyamsElias S, JayramGautam, KatesMax, PatelHiten D, PierorazioPhillip M

Paper Details 
Original Abstract of the Article :
OBJECTIVE: The objectives of the present study were analyze specific comorbidities associated with survival and actual causes of death for patients with small renal masses, and to suggest a simplified measure associated with decreased overall survival specific to this population. METHODS: The Surve...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/iju.12527

データ提供:米国国立医学図書館(NLM)

Comorbidities and Kidney Cancer: A Complex Relationship

This study examines the impact of comorbidities on survival outcomes for patients with localized T1a kidney cancer. The researchers analyzed data from the Surveillance, Epidemiology, and End Results-Medicare database to identify the specific comorbidities associated with decreased survival.

Comorbidities and Survival

The study revealed that a range of comorbidities, including congestive heart failure, chronic kidney disease, peripheral vascular disease, chronic obstructive pulmonary disease, diabetes, and cerebrovascular disease, were associated with decreased overall survival among patients with T1a kidney cancer.

Managing Comorbidities and Kidney Cancer

Individuals with comorbidities and localized T1a kidney cancer should consult with their doctor to develop a personalized treatment plan. Managing comorbidities effectively can improve overall health and potentially enhance survival outcomes.

Dr.Camel's Conclusion

This study highlights the complexities of managing kidney cancer in the presence of comorbidities. It emphasizes the need for careful assessment, personalized treatment, and proactive management of underlying health conditions to improve patient outcomes.
Date :
  1. Date Completed 2015-07-08
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

24931430

DOI: Digital Object Identifier

10.1111/iju.12527

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.